Updated Jul 16, 2026
Vincent Mark D. has filed 1 SEC Form 4 filing across 1 company in the last 90 days.

Vincent Mark D. is listed in Aptose Biosciences Inc.'s SEC filings as a corporate insider, with the most recent filing dated July 1, 2026. Publicly available sources do not disclose a detailed personal or professional biography for this individual beyond their appearance in the Aptose filing. There is no widely corroborated information about this person’s career history, background, or notable achievements outside the SEC context provided.
| Role | Insider |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-01 | APTO | Aptose Biosciences Inc. | D — Derivative transaction | 14 | $1.72 | $24 |
Vincent Mark D. is listed in Aptose Biosciences Inc.'s SEC filings as a corporate insider, with the most recent filing dated July 1, 2026. Publicly available sources do not disclose a detailed personal or professional biography for this individual beyond their appearance in the Aptose filing. There is no widely corroborated information about this person’s career history, backgr…
1 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Vincent Mark D. profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.